Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.25p
   
  • Change Today:
    -0.35p
  • 52 Week High: 12.50
  • 52 Week Low: 5.62
  • Currency: UK Pounds
  • Shares Issued: 405.37m
  • Volume: 8,193,004
  • Market Cap: £37.50m
  • RiskGrade: 348

Regulatory News

Holding(s) in Company 02-Oct-2025 14:57 RNS
Holding(s) in Company 01-Oct-2025 14:43 RNS
Holding(s) in Company 01-Oct-2025 07:00 RNS
CE Mark application submission 01-Oct-2025 07:00 RNS
Holding(s) in Company 30-Sep-2025 16:02 RNS
Holding(s) in Company 29-Sep-2025 17:18 RNS
Holding(s) in Company 29-Sep-2025 14:28 RNS
Holding(s) in Company 29-Sep-2025 09:32 RNS
Holding(s) in Company 29-Sep-2025 07:00 RNS
Holding(s) in Company 26-Sep-2025 12:17 RNS
£7.05m total gross proceeds from Fundraise 26-Sep-2025 07:00 RNS
Update Regarding Forward Guidance 24-Sep-2025 14:00 RNS
Additional Subscription for 11m Shares 24-Sep-2025 10:00 RNS
Investor Presentation and Revised Revenue Guidance 23-Sep-2025 07:00 RNS
Result of Fundraise 22-Sep-2025 17:30 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 9.25p
Change Today -0.35p
% Change -3.65 %
52 Week High 12.50
52 Week Low 5.62
Volume 8,193,004
Shares Issued 405.37m
Market Cap £37.50m
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 02-Oct-2025

Time Volume / Share Price
15:23 929,829 @ 9.25p
15:55 500,000 @ 9.50p
15:23 300,000 @ 9.50p
16:23 15,853 @ 9.14p
16:21 2,778 @ 9.14p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page